He Governing Council belonging Community of Madrid gave the green light this Wednesday to several acquisition contracts 1.7 million doses vaccines for administration according to the recommendations established by the region’s vaccination calendar for 2025 and 2026.
So the community invests 47 million euros in vaccines included in the calendar for all ages. They are part of the State Framework Agreement, to which Madrid is a party, and have been prepared taking into account the size of the population to be immunized and the available vaccine supplies.
They will be aimed at both healthy adults and children and at-risk groups. The doses purchased now will cover the needs for protection against various microorganisms that cause vaccine-preventable diseases in children, adults and the elderly, as well as in certain risk groups.
The community is investing 47 million euros in vaccines, which are included in the calendar for all ages.
The approved agreement involves the purchase of the vaccine. hexavalent (against hepatitis B, diphtheria, acellular pertussis, tetanus, polio and Haemophilus influenzae), as well as those aimed at preventing diphtheria and tetanus with reduced antigenic content or against meningococcus (conjugate vaccines against meningococcus C, as well as against serogroups A, B, C, Y and W in different preparations).
Vials for immunization against measles, rubella, mumps, chickenpox, meningococcus and hepatitis A and B. for both adults and children.
Vaccination is the most effective preventive measure for a healthy population, allowing control and even elimination of the disease. transmission of infection certain diseases and is a primary tool for certain risk groups due to their previous health status.
The Community of Madrid’s lifelong vaccination and immunization calendar includes protection against 18 Vaccine-Preventable Diseasesfrom the prenatal period to the age of 60 years.